期刊文献+

金刚健骨片对骨质疏松症模型大鼠骨组织OPG/RANKL/RANK系统影响的实验研究 被引量:6

Effect of Jingang Jiangu tablets on the OPG/RANKL/RANK system in a rat model of osteoporosis:an experimental study
原文传递
导出
摘要 目的:观察金刚健骨片对骨质疏松症模型大鼠体内OPG/RANKL/RANK系统表达的影响。方法:采用卵巢摘除法建立SD大鼠骨质疏松模型,设立假手术组、模型组(单纯去卵巢组)、雌激素组(尼尔雌醇组)和金刚健骨片组。造模成功后4周开始给药,给药12周后RT-PCR检测各组大鼠骨组织中OPG/RANKL/RANK mRNA的表达。结果:与假手术组比较,模型组的OPG表达降低、RANKL表达增加,差异具有统计学意义(P<0.05);与模型组比较,金刚健骨片组和雌激素组的OPG表达增高,RANKL表达降低,差异均有统计学意义(P<0.05);金刚健骨片组与雌激素组之间比较,差异无统计学意义(P>0.05);RANK的mRNA表达在各组之间比较,差异无统计学意义(P>0.05)。结论:采用卵巢摘除法成功建立大鼠骨质疏松模型;金刚健骨片可促进OPG在骨质疏松大鼠中的表达,抑制其RANKL的表达,这可能是金刚健骨片治疗骨质疏松症的作用机制之一。 Objective: To investigate the effect of Jingang Jiangu tablets on the OPG/RANKL/RANK system in a rat model of osteoporosis. Methods: Sprague-Dawley rats were ovariectomized to establish a model of osteoporosis and then divided into sham-operation group,model group( ovariectomization alone),estrogen group( nilestriol),and Jingang Jiangu tablet group. The drugs were administered since four weeks after the model was established,and RT-PCR was used to measure the mRNA expression of OPG/RANKL/RANK in bone tissue after 12 weeks of drug administration. Results: Compared with the sham-operation group,the model group had a significant reduction in the expression of OPG and a significant increase in the expression of RANKL( P 0. 05); compared with the model group,the Jingang Jiangu tablet group and the estrogen group had a significant increase in the expression of OPG and a significant reduction in the expression of RANKL( P 0. 05); there were no significant differences between the Jingang Jiangu tablet group and the estrogen group( P 0. 05); there was no significant difference in the mRNA expression of RANK between these groups( P 0. 05). Conclusion: A rat model of osteoporosis is successfully established by ovariectomization. Jingang Jiangu tablets can promote the expression of OPG and inhibit the expression of RANKL in rats with osteoporosis,which may be one of the mechanisms of action of Jingang Jiangu tablets in the treatment of osteoporosis.
作者 曹寅生 李喆 李木清 CAO Yin - sheng1 , LI Zhe2, LI Mu - qing3(1. The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha 410007, Hunan, China; 2. Hunan University of Chinese Medicine, Changsha 410208, Hunan, China ; 3. The Second Affiliated Hospital of Hunan University of Chinese Medicine,Changsha 410005 ,Hunan,Chin)
出处 《湖南中医杂志》 2018年第3期161-163,共3页 Hunan Journal of Traditional Chinese Medicine
基金 湖南省教育厅科学研究项目(编号:14C0864)
关键词 骨质疏松症 大鼠去卵巢模型 金刚健骨片 OPG/RANK/RANKL 实验研究 osteoporosis rat model of ovariectomization Jingang Jiangu tablet OPG/RANK/RANKL experimentalstudy
  • 相关文献

参考文献3

二级参考文献22

  • 1刘忠厚,杨定焯,朱汉民,王洪复,张柳,唐海,赵燕玲.中国人原发性骨质疏松症诊断标准(试行)[J].中国骨质疏松杂志,1999,5(1):1-3. 被引量:244
  • 2郭建生,欧莉,周军,王小娟,郭璇.筋骨片对骨性关节炎大鼠模型的影响[J].中国中药杂志,2006,31(3):232-235. 被引量:13
  • 3郭建生,欧莉,周军.筋骨片镇痛抗炎作用的实验[J].医药导报,2006,25(4):283-285. 被引量:2
  • 4于丽云,周学瀛,邢小平,夏维波,裴育,李梅,矫杰,孟迅吾,徐苓.北京地区汉族妇女绝经前后护骨素基因多态性与骨密度的关系(英文)[J].中国临床康复,2006,10(48):204-207. 被引量:3
  • 5No authors listecL Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med, 1993; 94(6) :646-650.
  • 6Simonet WS, Lacey DE, Dustan CR, et al. Osteoprotegerin:a novel secreted protein involved in the regulation of bone density. Cell, 1997; 89(2):309-319.
  • 7Luvizuto ER, Queiroz TP, Dias SM, et al. Histomorphometric analysis and immunolocalization of RANKI. and OPG during the alveolar healing process in female ovariectomized rats treated with oestrogen or raloxidfene. Arch Ored Biol, 2010; 55(1) :52-59.
  • 8Yasuda H. Bone and bone related bioehemical examinations. Bone and collagen related metabolites. Receptor activator of NF-kappaB ligand(RANKL). Clin Caldum, 2006; 16(6):964-970.
  • 9Stem A, Laughlin GA, Bergstrom J, et al. The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bemardo study. Eur J Endocrinol, 2007; 156(5) :555-562.
  • 10Indridason OS, Franzson L, Sigurdsson G. Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover. Osteoporos Int, 2005; 16(4) :417-423.

共引文献64

同被引文献100

引证文献6

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部